Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PRV
|
|||
| Former ID |
DIB008053
|
|||
| Drug Name |
PerCvax
|
|||
| Synonyms |
TerCvax; Ad6NSmut; AdCh3NSmut; TerCvax); HCV non structural region adenoviral vector prime/boost vaccine (HCV prophylaxis), Okairos; PerCvax + DNA plasmid boost (HCV therapeutic vaccine), Okairos; HCV non structural region adenoviral vector prime/boost vaccine + plasmid DNA (HCV therapeutic), Okairos
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 1/2 | [1] | |
| Company |
Glaxosmithkline; okairos
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Okairos. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.